Welcome

Costly Drugs Left Out of Import Rule Blunt Projected Savings

Sept. 25, 2020, 4:17 PM

Insulin and other expensive drugs aren’t included in a federal plan to import costly medications from other countries, making analysts skeptical it will deliver patients the “huge” savings the administration boasts.

The Trump administration can’t say yet how much patients may save or how much it may costs states to draw up their own plans to import pricey drugs from Canada.

“We will work to ensure the plans meet the requirements for state importation rules,” a senior administration official told reporters Friday. Officials also said precise savings were impossible to determine at this point, but that savings would be “huge” ...

To read the full article log in.